This article presents an updated version of M. Handelsman and M. Galvin's (1988) suggested written format for facilitating informed consent to psychotherapy. Significant changes in the psychotherapy profession during the past 15 years, and the revisions regarding informed consent in the American Psychological Association's (2002a) ethics code, form the rationale for this revision. Like the original, this form is a thorough list of questions that clients have a right to discuss with their psychologists. This revised version, which is intended to be illustrative rather than prescriptive, includes new questions addressing insurance/managed care issues, manualized and evidence-based psychotherapy, and psychopharmacology.
Like its predecessor (American Psychological Association [APA] , 1992), the new APA ethics code (APA, 2002a) includes standards for obtaining informed consent to psychotherapy. The new code, however, offers somewhat more detailed guidelines, including the directive for psychologists to "provide sufficient opportunity for the client/patient to ask questions and receive answers" (p. 1072). Handelsman and Galvin (1988) published a suggested list of such questions for psychologists to give to clients in writing, with the intention of facilitating the discussion and understanding of important therapy issues. Their set of questions seemed thorough at the time, with questions on the nature of the therapy, alternatives, appointments, confidentiality, money, and other issues. However, the psychotherapy field has witnessed significant changes in the 15 years since the publication of this list. Thus, we offer the current article as an update of Handelsman and Galvin's list for contemporary outpatient psychotherapy.
Of course, in recent years, numerous authors (e.g., Appelbaum, 1993; Haas & Cummings, 1991) have offered advice regarding informed consent to psychotherapy that has addressed contemporary issues. For example, Pope and Vasquez (1998) discussed the importance of making sure that clients understand how their managed care or insurance company may influence psychotherapy by limiting coverage or requiring disclosure of information. Shapiro (2001) also made specific suggestions for informed consent procedures regarding the release of client data to third-party payers, and Beahrs and Gutheil (2001) discussed the challenges of communicating information about third-party payers to clients. Acuff et al. (1999) considered a wide variety of ethical issues, including informed consent, in the context of managed care. All of these authors made clear recommendations about how to obtain informed consent to contemporary psychotherapy, but none offered the question-and-answer format proposed by Handelsman and Galvin (1988) and encouraged by the recently revised APA ethics code (APA, 2002a).
Prominent Issues in Contemporary Psychotherapy
As we look back on the past 15 years of developments in the field of psychotherapy, which issues have increased sufficiently in prominence or importance to merit inclusion in a revision of Handelsman and Galvin's (1988) list of questions? Or, to put this question in the context of the ethical concept of universalizability (Handelsman, 2001; Nagy, 2000) : If we (or our loved ones) were clients, what topics would we want to be included in the process of informed consent to modern psychotherapy? Certainly, as discussed above, managed care qualifies as such an issue. In fact, the revised APA ethics code now specifically mentions "involvement of third parties" (APA, 2002a (APA, , p. 1072 as a topic about which clients should be informed by psychologists. Numerous articles have described the increasing prevalence of managed care in the field of psychotherapy or the widespread influences that managed care has had on psychotherapy (e.g., Murphy, DeBernardo, & Shoemaker, 1998; Phelps, Eisman, & Kohout, 1998; Pingitore, Scheffler, Haley, Sentell, & Schwalm, 2001; Rothbaum, Bernstein, Haller, Phelps, & Kohout, 1998) . Additional studies (e.g., Pomerantz, 2000) have suggested that providing information to prospective clients about the effect of managed care on therapy evokes significant changes in attitudes toward therapy.
In addition (and in relation) to managed care, the rise of evidence-based and manualized psychotherapy practice appears to be another issue that merits inclusion in this update of Handelsman and Galvin (1988 empirically supported/validated treatments), the fundamental notion that a course of psychotherapy should consist of a structured set of interventions supported to some degree by data on its effectiveness has certainly risen to prominence in the past 15 years. In fact, multiple task forces have been formed by APA to consider various aspects of this issue, including one to develop a template for evaluating treatment guidelines (Stricker et al., 1999 ) and another to establish criteria for empirically supported treatments (Chambless et al., , 1998 ; Task Force on Promotion and Dissemination of Psychological Procedures, 1995). Scaturo (2001) discussed this movement within the context of the history and evolution of psychotherapy. The movement has been championed by some (e.g., Chambless, 1996) and criticized by others (e.g., Garfield, 1996) , but it has certainly risen in significance as a professional issue since 1988. In fact, in his discussion of informed consent, Plante (1999) argued that the movement toward empirically supported treatments has become so important to contemporary psychotherapy that "patients seeking treatment should be informed that empirically supported treatments exist, and the psychologist must let them know if they intend to use them (or not use them) in the treatment of the patient" (p. 400).
Prompting clients to ask about manualized therapies is important for several reasons. First, such questions provide an opportunity to discuss the strengths and weaknesses of evidence-based and manualized therapy practices, including their fallibility and the need to update them as warranted by continuing research. Second, empirical data suggest that clients prefer to know about inappropriate therapeutic techniques (Braaten & Handelsman, 1997) , and this type of information may help address that desire. Third, clients may have questions about the techniques being discussed, based on discussions with friends or articles in newspapers or self-help books they've been reading. Fourth, clients may be confused about why the therapy being described for them is different from the therapy their friend (who may have referred them) received from the same therapist.
In addition to the increase in the number of therapies, the number of types of therapists has increased. A majority of states now license professional counselors (American Counseling Association, 2002; Bradley, 1995) and marriage and family therapists (American Association for Marriage and Family Therapy, n.d.). Alternative therapies, treatments, and practitioners seem to be growing at an exponential rate (e.g., Arnold, 1995; Mamtani & Cimino, 2002; Sachs, 1997) . For this reason, we have added several questions designed to help therapists inform clients more fully about their credentials and approaches.
Another important development is that most therapists are required to provide information about their privacy policies and perhaps other information. The federal government's Health Insurance Portability and Accountability Act of 1996 (HIPAA; U.S. Department of Health and Human Services, 1996) is one important source of such requirements (Holloway, 2003a (Holloway, , 2003b . New clients may enter psychotherapy with a range of awareness of HIPAA regulations: They may have learned something about them through the media, other health providers may have provided some information, or they may be entirely ignorant of them. In any case, we have added a question specifically addressing HIPAA issues to provide clients with an opportunity to discuss the implications of this act regarding the confidentiality of different types of health information (e.g., psychotherapy notes as distinct from other types of patient information, electronically transmitted information; Holloway, 2003b ). This type of discussion is especially relevant considering the empirical evidence that clients are quite desirous of information about confidentiality (Braaten & Handelsman, 1997) .
Some states require therapists to provide written information to clients about therapist qualifications, credentials, and policies and about client rights. Our form is certainly not a substitute for any written information therapists provide. Rather, it is a complement that might increase the benefit of such written information.
Finally, we believe that the issue of psychopharmacology merits mention in our revised form. Of course, we recognize that most psychologists do not currently have prescription privileges, although psychologists have recently been making significant inroads toward obtaining prescription privileges (APA, 2002b). However, we see three reasons why some mention of psychopharmacology is warranted in our revised set of informed consent discussion questions. First, clients are far more aware of psychotropic drugs than they were in 1988. This is attributable to numerous factors, including the sheer proliferation of such drugs (it is now far more likely that a contemporary client personally knows someone who is taking drugs such as Paxil, Zoloft, or Prozac) and the millions of dollars spent in recent years on direct-to-consumer advertising of these drugs (Rosenthal, Berndt, Donohue, Frank, & Epstein, 2002) . Second, this increased public awareness of available drugs is combined with what may be an unclear distinction between psychiatrists and psychologists in the public eye (Bremer et al., 2001; Warner & Bradley, 1991) ; thus, the likelihood of a client arriving in a psychologist's office with the expectation that the psychologist has the capacity to prescribe medicine is considerable. Third, there is a greater likelihood that clients will be taking medications and will want to know if their therapist is knowledgeable about the drugs they are taking.
Specific Additions to Handelsman and Galvin's (1988) Form
The updated question form appears in the Appendix. It consists of Handelsman and Galvin's (1988) original form, with additions printed in bold. We have made a few minor wording changes to the 1988 original but have omitted none of the original questions.
The section of questions on insurance and managed care (Section VI) is entirely new and is the most significant addition to the original. It consists of five questions designed to facilitate open discussion of the effect of third-party involvement on the therapy process. The questions address numerous issues: information to be shared between the psychologist and the third party (in more detail than the parenthetical reference in Question A of Section IV); the power of the third party to control the length or goals of therapy; the possibility of appealing a decision made by the third party; and policies regarding changes in insurance status. They also give rise to discussions of payment options that do not involve third parties (i.e., self-pay).
The first section of questions (the "Therapy" section) features several entirely new questions and several repetitions of the follow-up question. The last question in this section ("Will this therapy follow a preplanned format or structure?") is intended to facilitate discussion about the use of therapy manuals or guidelines, but not necessarily in such professional terms. The purpose of this question is to give clients the opportunity to be informed about the extent to which their therapy will be directed by predetermined procedures and activities or determined in a more improvised or extemporaneous manner. The follow-up question ("How do you know?") appears three times in this section and once more in Section II. Each time, it follows a question that involves the issue of therapy efficacy or effectiveness. The purpose of this question is to give clients the opportunity to be informed about the evidence on which the psychologist is basing answers to questions about the extent to which therapy works. Of course, for most clients it would be inappropriate to answer such questions with detailed reports on outcome data, but some intelligible description of findings could be provided. Such findings could take a variety of forms, such as previous clinical trials demonstrating empirical support for a particular treatment of a particular presenting problem (as listed in Chambless et al., 1998) , more global outcome data supporting the therapeutic power of common factors (as described in Norcross, 2002) , or accountability data that are specific to an individual practitioner or clinic (Callaghan, 2001) . New questions also appear that more specifically address psychopharmacology, other approaches to therapy, HIPAA requirements, and credentials.
Discussion
Discussions based on these questions should complement, not replace, written informed consent documents to be signed by the client and conversations about therapy information documented in other ways. Discussions based on these questions should also be documented by the psychologist (APA, 2002a; Moline, Williams, & Austin, 1998) .
As stated in the original, it is not intended as a cookbook approach to obtaining informed consent . Clearly, this form can be adapted to meet the needs of specific clients. Although it is beyond the scope of this article, a similar question-and-answer approach can be taken with assessment, consultation, teaching, or any other professional activities.
It might be argued that this kind of form might actually get in the way of establishing a therapeutic alliance. The available empirical data suggest just the opposite; in several studies assessing the impact of the original form and other written materials, the presence of readable documents did not reduce and often increased potential clients' ratings of therapists (Handelsman, 1990; Handelsman & Martin, 1992; Sullivan, Martin, & Handelsman, 1993) , especially if the documents were presented in a personalized way (Wagner, Davis, & Handelsman, 1998) .
This updated question form offers many strengths. It facilitates open and honest discussion about important issues in psychotherapy, including common contemporary issues like third-party payment, manualization, and psychopharmacology, which reasonable people seeking contemporary psychotherapy would find relevant (Braaten & Handelsman, 1997; Canterbury v. Spence, 1972) . Discussions around this form may also improve the effectiveness of whatever written information therapists give their clients or ask them to read and sign. Such open discussion enables the growth of a strong therapeutic relationship between therapist and client (Appelbaum, Lidz, & Meisel, 1987; Handelsman, 2001) , one based on autonomy and empowerment through information rather than withholding, distrust, or patronization. Moreover, such a practice not only matches the recommendations of the newly revised APA ethics code (APA, 2002a), but it is also self-protective in that it helps psychologists to avoid legal problems (Plante, 1999) . As with the original form , discussion of these questions alone does not constitute a completed informed consent process, but it is one important facet of a process that will enable clients to make genuinely informed decisions regarding contemporary psychotherapy.
